
Please try another search
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Chongqing, China.
Name | Age | Since | Title |
---|---|---|---|
Xue Feng Leng | 52 | 2016 | Deputy General Manager and Vice Chairman |
Yuan Yuan | 42 | 2017 | Chairman of Supervisory Board |
Jiansheng Liang | 42 | 2021 | Chairman |
Geng Chen | 51 | 2020 | Independent Director |
Song Lin | 51 | 2022 | Deputy GM & Director |
Xujiang Chen | 51 | 2020 | Independent Director |
Hai Run Wang | 36 | 2023 | Director |
Changbi Li | 52 | 2020 | Independent Director |
Huichuan Xu | 46 | 2014 | Employee Supervisor |
Weiyan Tang | 39 | 2020 | Director |
Mingyue Tan | 31 | 2021 | Supervisor |
Rihua Ou | 48 | 2020 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review